Literature DB >> 33403595

Depression Augments Plasma APOA4 without Changes of Plasma Lipids and Glucose in Female Adolescents Carrying G Allele of APOA4 rs5104.

Qi Wei Guo1, Yan Jun Si1, Yi Lin Shen1, Xu Chen1, Mei Yang1, Ding Zhi Fang1, Jia Lin2.   

Abstract

The association of apolipoprotein AIV (APOA4) with depression or plasma levels of lipids and glucose has been inconsistently reported. However, interplays between APOA4 and depression on the levels have not been explored yet. The present study aimed to investigate plasma levels of APOA4, lipids, and glucose in adolescents with different genotypes of APOA4 rs5104 and with or without depression. Depressive symptoms were assessed in 631 adolescents by Beck Depression Inventory (BDI). A total score of 14 was defined as the cutoff point for depression. Plasma levels of triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), glucose, and insulin were measured by routine methods, and APOA4 by enzyme-linked immunosorbent assays. Genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism analyses and verified by DNA sequencing. Female adolescents had higher prevalence of depression than male subjects only in G allele carriers (p = 0.015), but not in AA homozygotes. Risk factors of depression and predictors of depression severity were different between G allele carriers and AA homozygotes. Lower levels of glucose (p = 0.003) were observed in male G allele carriers than those in male AA homozygotes and increased TG levels (p = 0.008) in female G allele carriers when compared with those in female AA homozygotes. When both APOA4 rs5104 and depression were taken into account, subjects with depression had higher levels of plasma APOA4 than adolescents without depression only in female G allele carriers (p = 0.043), but no significant changes of plasma lipids and glucose. Depression augments plasma APOA4 levels without changes of plasma lipids and glucose in female adolescents carrying G allele of APOA4 rs5104. These results may provide a novel explanation for the inconsistent relationship between depression, APOA4, and plasma levels of lipids and glucose in the literature.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Apolipoprotein A4; Depression; Glucose; Lipids; Single nucleotide polymorphism

Mesh:

Substances:

Year:  2021        PMID: 33403595     DOI: 10.1007/s12031-020-01766-7

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  17 in total

1.  Serum lipid concentrations in patients with major depressive disorder.

Authors:  S O Olusi; A A Fido
Journal:  Biol Psychiatry       Date:  1996-12-01       Impact factor: 13.382

2.  Associations between plasma lipid parameters and APOC3 and APOA4 genotypes in a healthy population are independent of dietary cholesterol intake.

Authors:  Kristin L Herron; Ingrid E Lofgren; Xian Adiconis; Jose M Ordovas; Maria Luz Fernandez
Journal:  Atherosclerosis       Date:  2005-04-21       Impact factor: 5.162

3.  Apolipoprotein A-IV regulates chylomicron metabolism-mechanism and function.

Authors:  Alison B Kohan; Fei Wang; Xiaoming Li; Suzanne Bradshaw; Qing Yang; Jody L Caldwell; Tera M Bullock; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-29       Impact factor: 4.052

4.  Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression.

Authors:  Lucia Carboni; Serena Becchi; Chiara Piubelli; Alessandra Mallei; Roberto Giambelli; Maria Razzoli; Aleksander A Mathé; Maurizio Popoli; Enrico Domenici
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-05-23       Impact factor: 5.067

5.  Blood-based immune-endocrine biomarkers of treatment response in depression.

Authors:  Man K Chan; Jason D Cooper; Mariska Bot; Tom K Birkenhager; Veerle Bergink; Hemmo A Drexhage; Johann Steiner; Matthias Rothermundt; Brenda W J H Penninx; Sabine Bahn
Journal:  J Psychiatr Res       Date:  2016-08-31       Impact factor: 4.791

6.  Behavioral health mediators of the link between posttraumatic stress disorder and dyslipidemia.

Authors:  Paul A Dennis; Christi S Ulmer; Patrick S Calhoun; Andrew Sherwood; Lana L Watkins; Michelle F Dennis; Jean C Beckham
Journal:  J Psychosom Res       Date:  2014-05-14       Impact factor: 3.006

7.  Age- and sex-specific causal effects of adiposity on cardiovascular risk factors.

Authors:  Tove Fall; Sara Hägg; Alexander Ploner; Reedik Mägi; Krista Fischer; Harmen H M Draisma; Antti-Pekka Sarin; Beben Benyamin; Claes Ladenvall; Mikael Åkerlund; Mart Kals; Tõnu Esko; Christopher P Nelson; Marika Kaakinen; Ville Huikari; Massimo Mangino; Aline Meirhaeghe; Kati Kristiansson; Marja-Liisa Nuotio; Michael Kobl; Harald Grallert; Abbas Dehghan; Maris Kuningas; Paul S de Vries; Renée F A G de Bruijn; Sara M Willems; Kauko Heikkilä; Karri Silventoinen; Kirsi H Pietiläinen; Vanessa Legry; Vilmantas Giedraitis; Louisa Goumidi; Ann-Christine Syvänen; Konstantin Strauch; Wolfgang Koenig; Peter Lichtner; Christian Herder; Aarno Palotie; Cristina Menni; André G Uitterlinden; Kari Kuulasmaa; Aki S Havulinna; Luis A Moreno; Marcela Gonzalez-Gross; Alun Evans; David-Alexandre Tregouet; John W G Yarnell; Jarmo Virtamo; Jean Ferrières; Giovanni Veronesi; Markus Perola; Dominique Arveiler; Paolo Brambilla; Lars Lind; Jaakko Kaprio; Albert Hofman; Bruno H Stricker; Cornelia M van Duijn; M Arfan Ikram; Oscar H Franco; Dominique Cottel; Jean Dallongeville; Alistair S Hall; Antti Jula; Martin D Tobin; Brenda W Penninx; Annette Peters; Christian Gieger; Nilesh J Samani; Grant W Montgomery; John B Whitfield; Nicholas G Martin; Leif Groop; Tim D Spector; Patrik K Magnusson; Philippe Amouyel; Dorret I Boomsma; Peter M Nilsson; Marjo-Riitta Järvelin; Valeriya Lyssenko; Andres Metspalu; David P Strachan; Veikko Salomaa; Samuli Ripatti; Nancy L Pedersen; Inga Prokopenko; Mark I McCarthy; Erik Ingelsson
Journal:  Diabetes       Date:  2015-02-23       Impact factor: 9.461

8.  Serum proteomic profiling of major depressive disorder.

Authors:  M Bot; M K Chan; R Jansen; F Lamers; N Vogelzangs; J Steiner; F M Leweke; M Rothermundt; J Cooper; S Bahn; B W J H Penninx
Journal:  Transl Psychiatry       Date:  2015-07-14       Impact factor: 6.222

9.  A genome-wide association meta-analysis on apolipoprotein A-IV concentrations.

Authors:  Claudia Lamina; Salome Friedel; Stefan Coassin; Rico Rueedi; Noha A Yousri; Ilkka Seppälä; Christian Gieger; Sebastian Schönherr; Lukas Forer; Gertraud Erhart; Barbara Kollerits; Pedro Marques-Vidal; Janina Ried; Gerard Waeber; Sven Bergmann; Doreen Dähnhardt; Andrea Stöckl; Stefan Kiechl; Olli T Raitakari; Mika Kähönen; Johann Willeit; Ludmilla Kedenko; Bernhard Paulweber; Annette Peters; Thomas Meitinger; Konstantin Strauch; Terho Lehtimäki; Steven C Hunt; Peter Vollenweider; Florian Kronenberg
Journal:  Hum Mol Genet       Date:  2016-07-12       Impact factor: 6.150

10.  Plasma biomarkers of depressive symptoms in older adults.

Authors:  S E Arnold; S X Xie; Y-Y Leung; L-S Wang; M A Kling; X Han; E J Kim; D A Wolk; D A Bennett; A Chen-Plotkin; M Grossman; W Hu; V M-Y Lee; R Scott Mackin; J Q Trojanowski; R S Wilson; L M Shaw
Journal:  Transl Psychiatry       Date:  2012-01-03       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.